Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Benjamin Neale
Brigham and Women's Hospital, Department: Na
Should you be removed from our database? Contact us at [email protected]. Read more below.
Deep Genomics, Inc.
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Deep Genomics, Inc. is a private company focused on developing machine learning methods that can find patterns in datasets and infer computer models of how cells read the genome and generate biomolecules. The company’s technology provides a causal interpretation for genetic variation. The company is also building algorithms to model splicing and is developing genetic therapies. The research project seeks to characterize genetic architecture of psychiatric and other complex diseases, quantify heritability due to rare and common alleles, and identify functional groups of alleles and gene sets that are mostly responsible for the heritable component of disease risk. The research project will also develop new methods to identify disease risk loci in sequencing studies. The institution determined that the methods developed under this research grant could be of interest to the company. Given the close connection between the aims of the company and the research project, the institution determined that the interests of the company could be affected by the research and that Dr. Neale’s financial interest creates a financial conflict of interest.
Rare and common variants in complex disease
This renewal application proposes to characterize genetic architecture of psychiatric and other complex diseases. We will quantify heritability due to rare and common alleles, and identify functional groups of alleles and gene sets that are mostly responsible for the heritable component of disease risk. Building on the results we will develop new methods to identify disease risk loci in sequencing studies.
Filed on January 18, 2018.
Tell us what you know about Benjamin Neale's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Benjamin Neale”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Benjamin Neale | Massachusetts General Hospital | Conflict of Interest | Deep Genomics, Inc. | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.